OTCMKTS:CRGS

CurAegis Technologies Stock Forecast, Price & News

$0.04

0.00 (0.00 %)

(As of 03/3/2021 12:00 AM ET)

Add

Compare

Today's Range

$0.04

Now: $0.04▼

$0.05

50-Day Range

$0.02

MA: $0.05▼

$0.08

52-Week Range

$0.01

Now: $0.04▼

$0.15

Volume3,396 shs

Average Volume125,079 shs

Market Capitalization$2.16 million

P/E RatioN/A

Dividend YieldN/A

Beta-1.06

CurAegis Technologies, Inc. develops and markets advanced technologies in the areas of safety and wellness. It focuses on the commercialization of the myCadian system, a wellness and safety system that enables the user to anticipate and avert undesired or disastrous situations caused by the degradation of alertness; and Z-Coach, a proprietary sleep training and education solution to correct sleep issues and enhance overall wellness for industry professionals and corporate workers. The company was formerly known as Torvec, Inc. and changed its name to CurAegis Technologies, Inc. in June 2016. CurAegis Technologies, Inc. was founded in 1996 and is based in Rochester, New York.

Headlines

CurAegis Technologies, Inc. appoints Lance F. Drummond to Board of Directors
May 28, 2020 | www.bloomberg.com

CurAegis Technologies Inc.
March 22, 2020 | www.barrons.com

CurAegis Technologies (CRGS) Earnings Report Date
November 2, 2019 | www.nasdaq.com

See More Headlines

Industry, Sector and Symbol

Stock Exchange OTCMKTS

Industry Motor vehicle parts & accessories

Sub-IndustryN/A

SectorBusiness Services

Current SymbolOTCMKTS:CRGS

Previous SymbolOTCMKTS:TOVC

CUSIPN/A

CIK1063197

Webwww.curaegis.com

Phone585-254-1100

Employees7

Year FoundedN/A

Debt

Debt-to-Equity RatioN/A

Current Ratio0.02

Quick Ratio0.02

Price-To-Earnings

Trailing P/E RatioN/A

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual Sales$10,000.00

Price / Sales216.10

Cash FlowN/A

Price / Cash FlowN/A

Book Value($0.25) per share

Price / Book-0.17

Profitability

EPS (Most Recent Fiscal Year)N/A

Net Income$-4,280,000.00

Net Margins-19,936.37%

Return on EquityN/A

Return on Assets-737.76%

Miscellaneous

Outstanding Shares51,453,000

Market Cap$2.16 million

Next Earnings Date3/5/2021 (Estimated)

OptionableNot Optionable

MarketRank^™

Overall MarketRank^™

0.67 out of 5 stars

Business Services Sector

287th out of 442 stocks

Motor Vehicle Parts & Accessories Industry

46th out of 58 stocks

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for CurAegis Technologies.

2.5 Community Rank

Outperform Votes
CurAegis Technologies has received 58 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
CurAegis Technologies has received 58 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
CurAegis Technologies has received 50.00% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about CurAegis Technologies and other stocks. Vote “Outperform” if you believe CRGS will outperform the S&P 500 over the long term. Vote “Underperform” if you believe CRGS will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
CurAegis Technologies does not currently pay a dividend.
Dividend Growth
CurAegis Technologies does not have a long track record of dividend growth.

0.8 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, CurAegis Technologies insiders have not sold or bought any company stock.
Percentage Held by Insiders
40.00% of the stock of CurAegis Technologies is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
Only 0.05% of the stock of CurAegis Technologies is held by institutions.

0.0 Earnings and Valuation

See Top Rated MarketRank™ Stocks Here

$0.04

0.00 (0.00 %)

(As of 03/3/2021 12:00 AM ET)

30 days | 90 days | 365 days | Advanced Chart

Receive CRGS News and Ratings via Email

Sign-up to receive the latest news and ratings for CRGS and its competitors with MarketBeat's FREE daily newsletter.

CurAegis Technologies (OTCMKTS:CRGS) Frequently Asked Questions

What stocks does MarketBeat like better than CurAegis Technologies?

Wall Street analysts have given CurAegis Technologies a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but CurAegis Technologies wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is CurAegis Technologies' next earnings date?

CurAegis Technologies is scheduled to release its next quarterly earnings announcement on Friday, March 5th 2021.
View our earnings forecast for CurAegis Technologies.

How were CurAegis Technologies' earnings last quarter?

CurAegis Technologies, Inc. (OTCMKTS:CRGS) issued its quarterly earnings results on Wednesday, May, 13th. The company reported ($0.02) earnings per share (EPS) for the quarter.
View CurAegis Technologies' earnings history.

How has CurAegis Technologies' stock price been impacted by COVID-19 (Coronavirus)?

CurAegis Technologies' stock was trading at $0.08 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, CRGS stock has decreased by 47.5% and is now trading at $0.0420.
View which stocks have been most impacted by COVID-19.

Who are CurAegis Technologies' key executives?

CurAegis Technologies' management team includes the following people:

Mr. James R. Donnelly, Pres, CEO, COO & Director (Age 42, Pay $175k)
Mr. Richard A. Kaplan, Exec. Director (Age 75, Pay $65k)
Mr. Keith E. Gleasman, Co-Founder & Independent Director (Age 74)
Mr. Jason Burke, Chief Financial Officer (Age 48)
Mr. Richard B. Sullivan, Corp. Counsel
Mr. Brandon Hudson, Head of Product

Who are some of CurAegis Technologies' key competitors?

Some companies that are related to CurAegis Technologies include Omnitek Engineering (OMTK), Puradyn Filter Technologies (PFTI), American International Industries (AMIN), ATC Venture Group (ATCV), Proliance International (PLNTQ), QF Liquidation (QTWWQ) and Sense Technologies (SNSGF).
View all of CRGS's competitors.

What other stocks do shareholders of CurAegis Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other CurAegis Technologies investors own include Allena Pharmaceuticals (ALNA), Arbutus Biopharma (ABUS), Matinas BioPharma (MTNB), Acasti Pharma (ACST), Aldeyra Therapeutics (ALDX), Ampio Pharmaceuticals (AMPE), Ampliphi Biosciences (APHB), BIOLASE (BIOL), Clearside Biomedical (CLSD) and LiveXLive Media (LIVX).

What is CurAegis Technologies' stock symbol?

CurAegis Technologies trades on the OTCMKTS under the ticker symbol "CRGS."

How do I buy shares of CurAegis Technologies?

Shares of CRGS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is CurAegis Technologies' stock price today?

One share of CRGS stock can currently be purchased for approximately $0.04.

How much money does CurAegis Technologies make?

CurAegis Technologies has a market capitalization of $2.16 million and generates $10,000.00 in revenue each year.

How many employees does CurAegis Technologies have?

CurAegis Technologies employs 7 workers across the globe.

What is CurAegis Technologies' official website?

The official website for CurAegis Technologies is www.curaegis.com.

Where are CurAegis Technologies' headquarters?

CurAegis Technologies is headquartered at 350 LINDEN OAKS, ROCHESTER NY, 14625.

How can I contact CurAegis Technologies?

CurAegis Technologies' mailing address is 350 LINDEN OAKS, ROCHESTER NY, 14625. The company can be reached via phone at 585-254-1100 or via email at [email protected]

This page was last updated on 3/4/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here